F

Fortress Biotech

FBIO

2.09000
USD
-0.01
(-0.48%)
Market Closed
Volume
12,533
EPS
0
Div Yield
0
P/E
-0
Market Cap
41,293,257
Related Instruments
A
ALNY
31.19
(13.13%)
268.66 USD
AMGN
2.78
(0.84%)
335.22 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
I
INCY
-0.680
(-1.05%)
64.390 USD
REGN
13.14
(1.22%)
1,091.19 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: Fortress Biotech

Sector: Healthcare
Industry: Biotechnology
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.